Our live Investing Matters Podcast Special which took place at the Master Investor Show discussing 'How undervalued is the UK stock market?', has just been released. Listen here.
Woodford stock pick 4D Pharma
collapses
Sabah Meddings
Sunday June 26 2022, 12.01am, The Sunday Times
nil 4G URN © 98% (
+
98
T Woodford stoc...
Search
A drugmaker that was once a British biotech star worth more than £600 million has gone into
an administration that could wipe out hundreds of small shareholders.
4D Pharma, which won early backing from fallen stockpicker Neil Woodford, suspended its
shares on Friday after its lender demanded repayment of a $12.5 million (€10.2 million) loan
It said efforts to secure extra funding had "proved challenging".
4D Pharma had agreed a $30 million loan with Oxford Finance in July last year, handing it
security over assets. Last week the lender called in administrators Interpath Advisory, who
are hunting for a buyer.
The collapse comes just months after the AlM-listed company launched on Nasdaq via a
blank-cheque vehicle.
Company has filed a NAAA3 application for joint administrator they want a say.
I don’t know how we go from talking about pay rises 3 days ago to this. Have a Q & A etc it’s mind boggling and I’m very confused. They would have known about the financing issue in April I feel mislead. Especially as myself and others topped up thinking we have a cash runway till x date at the very least.
For those finding it hard to cope with their investment in @4dpharmaplc #DDDD $LBPS there is an investor support group
****/+AZK8GfQVBDM3Y…
Don’t feel like your alone.
Please vote guys. We are all in this together.
https://twitter.com/slimgreekwasfat/status/1540704113628811265?s=28&t=_b4gq9svu10JIgfXHpHBRA
Send a message to the board please vote they are ccd
Directors own too many shares for this to be over.
One positive whiff of funding news and this bags. Oversold. Many keep focusing on dilution. They took Oxford for a reason. To not dilute. They are just covering bases. They said in the financial results they inferred something was there just not signed yet so going concern.
This is massively undervalued and yes I have still been topping up.
With our pipeline and looking what others have done eg $MCRB it is very possible.
Many companies in the US similar have x7 to even x39 their SP. I’d say we could reach £6-£8.
I think personally however we will be sold soon to Merck for around 2-3$ billion purely because of how important we are to keytruda and now we have a Pfizer trial I think they will go for it before that blossoms. Plus the vaccine collaboration and our discovery platform.
I wouldn’t be surprised if we all wake up to a massive buy out RNS one day.
All imo of course gla
Blautix maybe the diamond we didn?t think it was
https://www.clinicaltrialsarena.com/comment/microbiome-targeting-pipeline-immunological-indications/
Very positive
https://twitter.com/slimgreekwasfat/status/1392608831444750337?s=21
Added some more today, so much news in the coming months could send this flying.
I did for years.
Then they made the share less liquid to trade so I stayed put then they issued more then more. Asset is good but are they ever going to be profitable? Me myself I just see convenient excuses to blame it on but I won’t post again as I know others are still here I’m just human and furious.
Anyway good luck to all those who remain. Apologies it may come good but for me this affair is over.
I know 2 well known I can think off good luck to them it’s just too much jam tomorrow and excuse after excuse I’ve added to #EEE with my leftovers instead.
I just sold my entire holding in this piece of crap. Held for three years jam tomorrow always got shafted sad to say lost over 20 grand but too much jam today tomorrow and the next day. You can check me out on this board over the years so I’m not a deramper but I’m out.
Expecting this to rerate any day now. So many major catalysts incoming, compares to our US peers it’s only a matter of when let’s break 1.54 resistance then off we go...
We will be multiples of the current SP within the next few months if all goes to plan which I’m confident it will.
Seres, always comes to mind, look at their value compared to us. We should be a highly probable multi bagger of 2021.
With all ducks lined up in a row this could be a life changing share for both those receiving treatment and shareholders alike.
Gla